Bruker Corp
NASDAQ:BRKR

Watchlist Manager
Bruker Corp Logo
Bruker Corp
NASDAQ:BRKR
Watchlist
Price: 58.25 USD 1.5% Market Closed
Market Cap: 8.8B USD
Have any thoughts about
Bruker Corp?
Write Note

Net Margin
Bruker Corp

9.4%
Current
12%
Average
0.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
9.4%
=
Net Income
304.9m
/
Revenue
3.2B

Net Margin Across Competitors

Country US
Market Cap 8.8B USD
Net Margin
9%
Country US
Market Cap 1.2T USD
Net Margin
9%
Country US
Market Cap 202.3B USD
Net Margin
14%
Country US
Market Cap 166.6B USD
Net Margin
18%
Country KR
Market Cap 66.8T KRW
Net Margin
24%
Country CH
Market Cap 38.4B CHF
Net Margin
9%
Country US
Market Cap 38.8B USD
Net Margin
20%
Country US
Market Cap 36.3B USD
Net Margin
9%
Country US
Market Cap 27B USD
Net Margin
21%
Country US
Market Cap 24.1B USD
Net Margin
17%
Country CN
Market Cap 162.8B CNY
Net Margin
21%
No Stocks Found

Bruker Corp
Glance View

Market Cap
8.8B USD
Industry
Life Sciences Tools & Services
Economic Moat
None

Bruker Corporation, a prominent entity in the analytical instrumentation sector, traces its roots back to Germany. Wholly devoted to advancing science and industry through meticulous precision, Bruker has carved out a niche in creating sophisticated analytical instruments that enable comprehensive research and diagnostics. Their portfolio spans a diverse range of technologies, including mass spectrometry, magnetic resonance imaging, X-ray analysis, and molecular spectroscopy, all meticulously designed to meet the exacting demands of their clientele. These sophisticated tools empower researchers, scientists, and industrial operators to obtain insights into the fundamental properties of materials and substances, thereby driving forward discoveries in medicine, chemistry, and material science. Bruker's financial health rests on a business model grounded in both innovation and strategic expansion. They generate revenue through the sale of their high-precision instruments as well as a steadily growing service segment that ensures their equipment remains at the cutting edge of functionality and reliability. Additionally, the company pursues collaborative ventures with academic institutions and industrial partners, creating a synergistic loop for product and market development. This strategic approach not only fortifies their market position but also nurtures long-term relationships, underpinning recurring revenues from service contracts and incremental technology upgrades. With a clear focus on driving quality and innovation, Bruker Corporation thrives in a competitive landscape, catering to the evolving needs of scientific discovery and industrial precision.

BRKR Intrinsic Value
68.24 USD
Undervaluation 15%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
9.4%
=
Net Income
304.9m
/
Revenue
3.2B
What is the Net Margin of Bruker Corp?

Based on Bruker Corp's most recent financial statements, the company has Net Margin of 9.4%.